Abstract
Aneurysmal subarachnoid hemorrhage (SAH) is a serious disease with high case fatality and morbidity. Early cerebral infarction has been suggested as a risk factor for poor outcome. We aimed to assess the pattern of early and delayed cerebral infarction after aneurysmal subarachnoid hemorrhage. We prospectively enrolled consecutive aneurysmal subarachnoid hemorrhage (SAH) patients presenting to an academic neurosurgical referral center (Prince of Wales Hospital, the Chinese University of Hong Kong) in Hong Kong. Cerebral infarction occurred in 24 (48 %) patients, in which 14 (28 %) had early cerebral infarction and 14 (28 %) had delayed cerebral infarction. Early anterior cerebral infarction occurred in a similar proportion of anterior and posterior circulation aneurysms (24 % vs. 21 %), whereas posterior circulation aneurysm patients had a higher proportion of early posterior cerebral infarction compared with anterior circulation aneurysm patients (18 % vs. 2 %). In conclusion, early cerebral infarction was common and different from delayed cerebral infarction.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Binaghi S, Colleoni ML, Maeder P, Uske A, Regli L, Dehdashti AR, Schnyder P, Meuli R (2007) CT angiography and perfusion CT in cerebral vasospasm after subarachnoid hemorrhage. AJNR Am J Neuroradiol 28:750–758
Dorhout Mees SM, Algra A, Vandertop WP, van Kooten F, Kuijsten HA, Boiten J, van Oostenbrugge RJ, Al-Shahi Salman R, Lavados PM, Rinkel GJ, van den Bergh WM (2012) Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial. Lancet 380:44–49
Juvela S, Siironen J (2012) Early cerebral infarction as a risk factor for poor outcome after aneurysmal subarachnoid haemorrhage. Eur J Neurol 19:332–339
Juvela S, Siironen J, Varis J, Poussa K, Porras M (2005) Risk factors for ischemic lesions following aneurysmal subarachnoid hemorrhage. J Neurosurg 102:194–201
Kivisaari RP, Salonen O, Servo A, Autti T, Hernesniemi J, Ohman J (2001) MR imaging after aneurysmal subarachnoid hemorrhage and surgery: a long-term follow-up study. AJNR Am J Neuroradiol 21:1143–1148
Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9:179–186
Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Bach D, Frey A, Marr A, Roux S, Kassell N (2011) Clazosentan, an endothelial receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol 10:618–625
Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Bach D, Frey A, Nowbakht P, Roux S, Kassell N (2012) Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling. Stroke 43:1463–1469
Nieuwkamp DJ, Setz LE, ALgra A, Linn FHH, de Rooij NK, Rinkel GJ (2009) Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol 8:635–642
Pallant J (2007) SPSS survival manual: a step by step guide to data analysis using SPSS for windows, 3rd edn. Open University Press/McGraw-Hill Education, Maidenhead/Berkshire
Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, Humphrey PR, Lang DA, Nelson R, Richards P, Sinar J, Bailey S, Skene A (1989) Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. Br Med J 298:636–642
Rabinstein AA, Friedman JA, Weignan SD, McClelland RL, Fulgham JR, Manno EM, Atkinson JL, Wijdicks EF (2004) Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 35:1862–1866
Rankin L (1957) Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J 2:200–215
Tong A, Man DW (2002) The validation of the Hong Kong Chinese version of the Lawton instrumental activities of daily living scale for institutionalized elderly persons. OTJR Occup Particip Health 22:132–142
Wong GK, Lam S, Ngai K, Wong A, Mok V, Poon WS, Cognitive Dysfunction after Aneurysmal Subarachnoid Haemorrhage Investigators (2012) Evaluation of cognitive impairment by the Montreal Cognitive Assessment in patients with aneurysmal subarachnoid haemorrhage: prevalence, risk factors, and correlations with 3 month outcome. J Neurol Neurosurg Psychiatry 83:1112–1117
Wong GK, Poon WS, Boet R, Chan MT, Gin T, Ng SC, Zee BC (2011) Health-related quality of life after aneurysmal subarachnoid hemorrhage: profile and clinical factors. Neurosurgery 68:1556–1561
Wong GK, Poon WS, Chan MT, Boet R, Gin T, Ng SC, Zee BC, Investigators IMASH (2010) Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial. Stroke 41:921–926
van Sieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn GJ (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19:604–607
Vilkki JS, Juvela S, Siironen J, Ilvoen T, Varis J, Porras M (2004) Relationship of local infarctions to cognitive and psychosocial impairment after aneurysmal subarachnoid hemorrhage. Neurosurgery 55:790–803
Vergouwen MD, Ilodigwe D, Macdonald RL (2011) Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects. Stroke 42:924–929
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Wong, G.K.C. et al. (2016). Early Cerebral Infarction after Aneurysmal Subarachnoid Hemorrhage. In: Applegate, R., Chen, G., Feng, H., Zhang, J. (eds) Brain Edema XVI. Acta Neurochirurgica Supplement, vol 121. Springer, Cham. https://doi.org/10.1007/978-3-319-18497-5_28
Download citation
DOI: https://doi.org/10.1007/978-3-319-18497-5_28
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-18496-8
Online ISBN: 978-3-319-18497-5
eBook Packages: MedicineMedicine (R0)